We are excited to announce the launch of a groundbreaking course, “Innovating Healthcare: From Concept to Reality,” a collaboration between […]
Rosenman Institute’s Inaugural Credited Course. Innovating Healthcare: From Concept to Reality
Event Categorie: In-person
8th Annual Rosenman Symposium – Innovating Healthcare Access: A New Era for the Future
UCSF Rosenman Institute’s Holiday Party 2023
At the UCSF Rosenman Institute’s end-of-year celebration, we shared cheerful moments of celebration! We want to express our heartfelt gratitude […]
Perfect Your Pitching and Pitch Decks for Investors: An Active Workshop to Receive Feedback from Industry Experts
Event Overview: Entrepreneurs and startups in the life science domain, join us for the opportunity to refine your pitching skills […]
The 2023 UCSF Rosenman Healthcare League. By Invitation Only!
2023 RISE Celebration: The Next Generation of Healthcare Leaders. By Invitation Only, Apply Below!
The 2023 UCSF Rosenman RISE event is a celebration dedicated to women, people of color, and LGBTQ+ founders. Through the […]
2023 Rosenman Innovators DEMO DAY
The 2023 Rosenman Innovators DEMO DAY is fast approaching! Join us in person on Tuesday, June 13th from 9:45 AM […]
The Next Chapter in Health Care – Doubling Down on Innovation
How Norwich Will Invest the Medtech Convergence Fund
Norwich Ventures, of which Aaron Sandoski is co-founder & managing director, recently closed the $90 million Medtech Convergence Fund. The firm intends to invest the fund in startups whose technologies embody the convergence of AI, data, or telehealth with traditional engineering. The pandemic, however, has changed the outlook for everyone, including VCs. Join this webinar to learn about Norwich’s approach to investing in the current climate.
Early-Stage Healthtech Investing
Ali Farahanchi is Managing Director at DHVC, an early-stage tech and life science fund in Palo Alto. With more than $650M assets under management and 100+ companies in its portfolio, DHVC invests in variety of areas in healthcare including therapeutics, diagnostics and tools, and digital health, with strong emphasis on novel mechanisms and data-driven platforms. Previously Ali has worked in research and in consulting roles in semiconductor and healthcare industries, and has obtained graduate degrees in engineering and management from MIT and University of Chicago.